Health Canada adds warning label to Oxford-AstraZeneca COVID-19 vaccine
CA, 26 Mar 2021
There has been concern and confusion over the Oxford-AstraZeneca vaccine including a small number of reports in Europe of extremely rare blood clots. There have not been any reports of blood clots in this country though Health Canada has added a warning of a potential side effect.
AstraZeneca said its COVID-19 vaccine was 76% effective at preventing symptomatic illness in a new analysis of its major U.S. trial — a tad lower than the level announced earlier this week in a report that was criticized for using outdated information.
U.S. health officials had publicly rebuked the drugmaker for not using the most up-to-date information when it published an interim analysis on Monday that said the vaccine was 79% effective.
For more info, please go to http://www.globalnews.ca
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #COVID #AstraZeneca